Mina Sooch

ProNAi

ProNAi Presents Cancer Drug Results, Expands Management Team

ProNAi Therapeutics Inc., a cancer drug development company, said last week that it had concluded its initial human clinical trial of PNT2258, a new type of nucleic acid drug.

WWJ Newsradio 950–11/11/2012

Follow

Get every new post delivered to your Inbox.

Join 2,368 other followers